Triple

T11444972
Position Surface form Disambiguated ID Type / Status
Subject Federal Commission for the Protection against Sanitary Risk E271239 entity
Predicate shortName P43 FINISHED
Object COFEPRIS
COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
E926318 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: COFEPRIS | Statement: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: COFEPRIS
Context triple: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. Federal Service for State Registration of Medicines
    The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. center for pharmaceutical research in the Philippines
    The center for pharmaceutical research in the Philippines is a leading national hub for drug discovery, development, and academic training in pharmacy and pharmaceutical sciences.
  • E. Pharmaceuticals and Medical Devices Agency Japan
    The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: COFEPRIS
Triple: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
Generated description
COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: COFEPRIS
Target entity description: COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. Federal Service for State Registration of Medicines
    The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. center for pharmaceutical research in the Philippines
    The center for pharmaceutical research in the Philippines is a leading national hub for drug discovery, development, and academic training in pharmacy and pharmaceutical sciences.
  • E. Pharmaceuticals and Medical Devices Agency Japan
    The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aadff8888190a13f253f0d460874 completed April 8, 2026, 7:22 p.m.
NER Named-entity recognition batch_69d8088a66f48190b2b4a56cd62097cf completed April 9, 2026, 8:14 p.m.
NED1 Entity disambiguation (via context triple) batch_69e5d3afe7fc8190acc8c803ff5efe5a completed April 20, 2026, 7:20 a.m.
NEDg Description generation batch_69e5d5cac9108190b7756329bfa320d3 completed April 20, 2026, 7:29 a.m.
NED2 Entity disambiguation (via description) batch_69e5d7fd235081909870476cbc9817b2 completed April 20, 2026, 7:38 a.m.
Created at: April 8, 2026, 9:35 p.m.